Montréal, Quebec, Canada | Fund Name | Location |
| Arthurian Life Sciences | England, London, United Kingdom |
| Blackstone Alternative Asset Management | New York, New York, United States |
| Chengdu Zhengjian | Chengdu, China, Sichuan |
| Coil | California, San Francisco, United States |
| Daishin Securities | Seoul, Seoul-t'ukpyolsi, South Korea |
| Daxinli Touzi | Beijing, Beijing, China |
| Expo 2020 | Dubai, United Arab Emirates |
| Fortune Capital | Coral Gables, Florida, United States |
| Hongxin Lianhua Venture Capital | China, Guangdong, Shenzhen |
| J.L. Easton Ventures | - |
| JBCHoldings | New York, New York, United States |
| Leslie Ventures | California, Portola Valley, United States |
| McKesson Ventures | California, San Francisco, United States |
| Mechanics Bank | California, Richmond, United States |
| Meihe Baizi Capital Management | Beijing, Beijing, China |
| Nextlaw Ventures | California, Palo Alto, United States |
| Shanghai Alliance Investment | China, Shanghai |
| Summit Action | New York, New York, United States |
| Traversant | Arizona, Phoenix, United States |
| Warehouse Investimentos | Brazil, São Paulo, Sao Paulo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Inspire Biotherapeutics | 15 Mar 2023 | Toronto, Ontario, Canada | |||
Triumvira Immunologics | $55M | 27 Aug 2020 | Austin, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Inspire Biotherapeutics | 15 Mar 2023 | Toronto, Ontario, Canada | |||
Triumvira Immunologics | $55M | 27 Aug 2020 | Austin, Texas, United States |
